Touchstone
Last syncNov 1, 2026, 6:55 PM ET

JAZZ

Jazz Pharmaceuticals Plc Health Care Pharmaceutical Preparations Russell 3000
$215.98Close $13.3BMarket cap $131.16 – $261.6252-week range Nov 2, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 5 of 8 trend conditions
  • Results soon Nov 2, 2026, in 1 day
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 3, 2026
Off 12-month high 17%
1wk up 0.9% price change
1mo down 6.7% price change
12-month return up 58% market up 11% · its own up 48%
F-score — — Not assessed
Altman Z 1.60 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 3.1× price / book
Earnings yield down 2.7% EBIT / enterprise value
Cheaper than 53% of the market · around average
Revenue growth up 5% year on year
EPS growth — latest quarter
Sales growth up 16% latest quarter · -4 pts
ROE down 8% return on equity
Free cash margin up 30% $1.3B FCF
D/E 1.00 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests

Repair signals

  • Long-term debt down 29% ($6.1B → $4.3B)

Trade setup

ATR% 3.0% $6.59 a day · 2×ATR $202.81
RS 69 / 99 vs the universe
Trend 5 / 8 under the 150/200-day, under the 50-day, RS under 70
Relative volume 1.3× vs 50-day average
Up/down volume 0.98 50 sessions
Implied move — no option chain · report Nov 2, 2026
Trend template · 5 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: passes
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: passes
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported Oct 26, 2026
Results reaction Oct 26, 2026-5% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $4.3B +5% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $2.4B FY2021 · $3.1B FY2022 · $3.7B FY2023 · $3.8B FY2024 · $4.1B FY2025 · $4.3B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$356.1M down to a loss
-$500M $0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $238.6M FY2021 · -$329.7M FY2022 · -$224.1M FY2023 · $414.8M FY2024 · $560.1M FY2025 · -$356.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $1.3B -4% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $884.6M FY2021 · $750.9M FY2022 · $1.2B FY2023 · $1.1B FY2024 · $1.4B FY2025 · $1.3B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net -8%
  • Free cash 30%
-20% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 10% · Free cash 37% FY2021 · Net -11% · Free cash 24% FY2022 · Net -6% · Free cash 34% FY2023 · Net 11% · Free cash 28% FY2024 · Net 14% · Free cash 33% FY2025 · Net -8% · Free cash 30%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $2.9B net debt
  • Cash
  • Long-term debt
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $1.1B · Long-term debt $1.8B FY2021 · Cash $591.4M · Long-term debt $6.0B FY2022 · Cash $881.5M · Long-term debt $5.7B FY2023 · Cash $1.5B · Long-term debt $5.1B FY2024 · Cash $2.4B · Long-term debt $6.1B FY2025 · Cash $1.4B · Long-term debt $4.3B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 61.44m +9.4% since FY2020
63.21m 56.17m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 56.17m FY2021 · 61.63m FY2022 · 63.21m FY2023 · 62.26m FY2024 · 60.63m FY2025 · 61.44m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $2.4B $3.1B $3.7B $3.8B $4.1B $4.3B
Operating income $378.1M $170.3M -$65.5M $578.6M $716.6M -$430.2M
Net income $238.6M -$329.7M -$224.1M $414.8M $560.1M -$356.1M
Net margin 10% -11% -6% 11% 14% -8%
Earnings per share $4.22 -$5.52 -$3.58 $5.76 $8.49 -$5.84
Free cash flow $884.6M $750.9M $1.2B $1.1B $1.4B $1.3B
Free cash margin 37% 24% 34% 28% 33% 30%
Cash $1.1B $591.4M $881.5M $1.5B $2.4B $1.4B
Long-term debt $1.8B $6.0B $5.7B $5.1B $6.1B $4.3B
Shareholders' equity $3.7B $4.0B $3.1B $3.7B $4.1B $4.3B
Shares outstanding 56.17m 61.63m 63.21m 62.26m 60.63m 61.44m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 3, 2026 Quarterly ↗ Jun 30, 2026 34d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Feb 24, 2026 Annual ↗ Dec 31, 2025 55d
Nov 5, 2025 Quarterly ↗ Sep 30, 2025 36d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Feb 26, 2025 Annual ↗ Dec 31, 2024 57d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 1, 2024 Quarterly ↗ Jun 30, 2024 32d
May 2, 2024 Quarterly ↗ Mar 31, 2024 32d
Feb 28, 2024 Annual ↗ Dec 31, 2023 59d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports

FiledDisclosed
Oct 26, 2026 Results ↗
Oct 9, 2026 Director or officer change ↗
Sep 23, 2026 Material agreement · New obligation ↗
Sep 15, 2026 Regulation FD ↗
Aug 31, 2026 Material agreement · New obligation · Unregistered share sale · Other events ↗
Aug 25, 2026 Other events ↗
Aug 10, 2026 Material agreement ↗
Aug 10, 2026 Regulation FD ↗
Aug 3, 2026 Results ↗
Jul 24, 2026 Shareholder vote ↗
May 29, 2026 Director or officer change ↗
May 5, 2026 Results ↗